The 6 months mortality rate of patients who survived to the second ICU stay was significantly higher than the patients who survived to the first admission but were not readmitted (46.7 vs 13.8%, p = 0.0007).
We sought to determine the incidence and risk factors for early (within 6 months) mortality after placement of a TPPM.
Combining HBO with subsequent normobaric hyperoxia even improved long-term outcome: at 6 months mortality was reduced (9 out of 22 vs. 3 out of 20 patients, p = 0.048), and overall neurological outcome was more favorable as evaluated with the sliding dichotomized Glasgow Outcome Score (8 out of 21 vs. 14 out of 19 patients, p = 0.024) [116].
Combining HBO with subsequent normobaric hyperoxia even improved long-term outcome: at 6 months mortality was reduced (9 out of 22 vs. 3 out of 20 patients, p = 0.048), and overall neurological outcome was more favorable as evaluated with the sliding dichotomized Glasgow Outcome Score (8 out of 21 vs. 14 out of 19 patients, p = 0.024) [ 116].
Interestingly, although age was the strongest predictor of six months mortality, it was not related to mortality prior to discharge.
We included 3669 patients (median age 15.5 months, mortality rate 6.1%%, median length of PICU stay 3 days).
ABGA parameters provide limited diagnostic value in patients with acute dyspnea, but pH is an independent predictor of 12 months mortality.
After a median follow-up of 44 months, mortality was significantly higher in patients receiving calcium-based binders than in those receiving sevelamer (p = 0.05) [ 41].
Six study clinics (Bauleni, Chawama, Chilenje, Chipata, George, and Mtendere) were operating for over 18 months at the time of randomization (range: 20 to 30 months as of October 1, 2006), and provided an estimated average 18-month mortality rate of 15.6 per 100 person-years.
Although heart rate (0.71) and systolic blood pressure (0.71) added minimally to model discrimination for 6-month mortality, history of congestive heart failure (0.76) – substituted for Killip class – added noticeable discriminative power.
